Biochemical Analysis of a Missense Mutation in Aceruloplasminemia
Overview
Affiliations
Aceruloplasminemia is an inherited neurodegenerative disease characterized by parenchymal iron accumulation secondary to loss-of-function mutations in the ceruloplasmin gene. To elucidate the molecular pathogenesis of aceruloplasminemia, the biosynthesis of a missense mutant ceruloplasmin (P177R) occurring in an affected patient was examined. Chinese hamster ovary cells transfected with cDNAs encoding secreted and glycosylphosphatidylinositol (GPI)-linked wild-type or P177R human ceruloplasmin were examined by pulse-chase metabolic labeling. These experiments, as well as immunofluorescent analysis and N-linked glycosylation studies, indicate that both the secreted and GPI-linked forms of the P177R mutant are retained in the endoplasmic reticulum (ER). The P177R mutation resides within a novel motif, which is repeated six times in human ceruloplasmin and is conserved in the homologous proteins hephaestin and factor VIII. Analysis of additional mutations in these motifs suggests a critical role for this region in ceruloplasmin trafficking and indicates that substitution of the arginine residue is critical to the ER retention of the P177R mutant. Metabolic labeling of transfected Chinese hamster ovary cells with (64)Cu indicates that the P177R mutant is retained in the ER as an apoprotein and that copper is incorporated into both secreted and GPI-linked ceruloplasmin as a late event in the secretory pathway. Taken together, these studies reveal new insights into the determinants of holoceruloplasmin biosynthesis and indicate that aceruloplasminemia can result from retention of mutant ceruloplasmin within the early secretory pathway.
Baj J, Bargiel J, Cabaj J, Skierkowski B, Hunek G, Portincasa P Int J Mol Sci. 2023; 24(20).
PMID: 37894749 PMC: 10606638. DOI: 10.3390/ijms242015071.
Wagatsuma T, Shimotsuma K, Sogo A, Sato R, Kubo N, Ueda S J Biol Chem. 2022; 298(6):102011.
PMID: 35525268 PMC: 9168625. DOI: 10.1016/j.jbc.2022.102011.
Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology.
Liu Z, Wang M, Zhang C, Zhou S, Ji G Diabetes Metab Syndr Obes. 2022; 15:695-711.
PMID: 35264864 PMC: 8901420. DOI: 10.2147/DMSO.S346648.
Production of Recombinant Human Ceruloplasmin: Improvements and Perspectives.
Bonaccorsi di Patti M, Cutone A, Nemcovic M, Pakanova Z, Barath P, Musci G Int J Mol Sci. 2021; 22(15).
PMID: 34360993 PMC: 8347646. DOI: 10.3390/ijms22158228.
Alfadhel M, Babiker A Sudan J Paediatr. 2018; 18(1):10-23.
PMID: 30166758 PMC: 6113785. DOI: 10.24911/SJP.2018.1.3.